Metalloproteinase inhibitors and the prevention of connective tissue breakdown
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 70 (3), 163-182
- https://doi.org/10.1016/0163-7258(96)00015-0
Abstract
No abstract availableKeywords
This publication has 195 references indexed in Scilit:
- Protease inhibitors: Role and potential therapeutic use in human cancerEuropean Journal Of Cancer, 1994
- Mutation of the Active Site Glutamic Acid of Human Gelatinase A: Effects on Latency, Catalysis, and the Binding of Tissue Inhibitor of Metalloproteinases-1Biochemistry, 1994
- Inhibition of Matrix Metalloproteinases by Peptidyl Hydroxamic AcidsBiochemical and Biophysical Research Communications, 1994
- The Recombinant Catalytic Domain of Human Neutrophil Collagenase Lacks Type I Collagen Substrate SpecificityBiochemical and Biophysical Research Communications, 1993
- Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblastsGene, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Inhibition of human collagenases by sulfur-based substrate analogsBiochemical and Biophysical Research Communications, 1991
- Transforming growth factor-beta causes partial inhibition of interleukin 1 — Stimulated cartilage degradation in vitroBiochemical and Biophysical Research Communications, 1989
- Fibroblast growth factor enhances the interleukin-1-mediated chondrocytic protease releaseBiochemical and Biophysical Research Communications, 1986
- Metal binding peptide inhibitors of vertebrate collagenaseBiochemical and Biophysical Research Communications, 1981